| pubmed-article:19620006 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C0003448 | lld:lifeskim |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C0038477 | lld:lifeskim |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:19620006 | lifeskim:mentions | umls-concept:C0205198 | lld:lifeskim |
| pubmed-article:19620006 | pubmed:issue | 16 | lld:pubmed |
| pubmed-article:19620006 | pubmed:dateCreated | 2009-8-11 | lld:pubmed |
| pubmed-article:19620006 | pubmed:abstractText | A series of 4-quinolylhydrazones was synthesized and tested in vitro against Mycobacterium tuberculosis. At a concentration of 6.25microg/mL, most of the newly synthesized compounds displayed 100% inhibitory activity against M. tuberculosis in cellular assays. Further screening allowed the identification of very potent antitubercular agents. Compound 4c was also tested in a time-course experiment and against mtb clinical isolates, displaying interesting results. | lld:pubmed |
| pubmed-article:19620006 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19620006 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19620006 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19620006 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19620006 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19620006 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19620006 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19620006 | pubmed:issn | 1464-3391 | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:DeloguGiovann... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:CampianiGiuse... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:ButiniStefani... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:GemmaSandraS | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:KumarVinodV | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:NovellinoEtto... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:SaviniLuisaL | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:ChiasseriniLu... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:AltarelliMari... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:CocconeSalvat... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:ClarizioSandr... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:TripaldiPiera... | lld:pubmed |
| pubmed-article:19620006 | pubmed:author | pubmed-author:CamodecaCater... | lld:pubmed |
| pubmed-article:19620006 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19620006 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:19620006 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:19620006 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19620006 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19620006 | pubmed:pagination | 6063-72 | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:meshHeading | pubmed-meshheading:19620006... | lld:pubmed |
| pubmed-article:19620006 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19620006 | pubmed:articleTitle | Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies. | lld:pubmed |
| pubmed-article:19620006 | pubmed:affiliation | European Research Centre for Drug Discovery & Development, Università di Siena, Italy. | lld:pubmed |
| pubmed-article:19620006 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19620006 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19620006 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19620006 | lld:chembl |
